Skip to content

HOMEOPHARMA

Active
Private limited companyfounded 20215 yrs activeDoverstraat 132-134, 1070 Anderlecht, BelgiumKBO/BCE: BE 0767.692.543

The computed 12-month bankruptcy probability of HOMEOPHARMA is 6.0% (elevated). The 2025 annual accounts show equity of €6k and a net result of €-5k. Equity is shrinking by ~93.6% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
47 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0=
Solvency82▲+20
Growth32=
Track record94
Bankruptcy probability, 12 months
6.0% Elevated
0%0.5%1.5%4%10%≥ 25%
No publishable credit limit; credit only on tighter terms
Liquidity ample (current ratio 2.33 against 1.59 in 2023; short-term debt: 42.9% and cash: 100% of total assets), and 42.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 5 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
57.1%
Return on assets
-48.5%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 26-03-2026, 35 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
35 d early
2023
76 d late
2022
442 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
21-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€6k▼ 56.3%
2023 · €14k
2022: €45k 2023: €14k
2022 → 2025
Total assets
€11k▼ 71.7%
2023 · €37k
2022: €58k 2023: €37k
2022 → 2025
Net result
€-5k▲ 83.5%
2023 · €-31k
2022: €42k 2023: €-31k
2022 → 2025
Working capital
€6k▼ 56.3%
2023 · €14k
2022: €45k 2023: €14k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202220232025Trend
Equity€45k-€14k▼ 69.2%€6k▼ 56.3%
Operating result€52k-€-31k€-2k▲ 92.7%
Net result€42k-€-31k€-5k▲ 83.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-50k€-25k€0€25k€50kOperating result 2022: €52k€52kNet result 2022: €42k€42kOperating result 2023: €-31k€-31kNet result 2023: €-31k€-31kOperating result 2025: €-2k€-2kNet result 2025: €-5k€-5k202220232025
The operating result is €-2k in 2025, compared with €-31k in 2023. Comparable figures for the intervening years are unavailable.
Balance-sheet composition
2025 in colour, 2023 as the grey bar beneath
Equity and liabilities €11k
Equity €6k▼ 56.3%
Debt €5k▼ 80.7%
The debt ratio falls from 63.0% to 42.9%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2023
Solvency
57.1%
2023 · 37.0%
Current ratio
2.33
2023 · 1.59
Quick ratio
2.33
2023 · 1.59
Debt / equity
0.75
2023 · 1.70
ROE
-84.9%
2023 · -224.6%
ROA
-48.5%
2023 · -83.1%
Debt
€5k
2023 · €23k
Debt ≤ 1 year
€5k
2023 · €23k
Income taxes
€3k
2023 · €0
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2023
Balance sheet Code20232025
Assets
Total assets20/58€37k€11k
Current assets29/58€37k€11k
Amounts receivable within one year40/41€0-
Trade receivables40€0-
Cash at bank and in hand54/58€37k€11k
Equity and liabilities
Total equity and liabilities10/49€37k€11k
Equity10/15€14k€6k
Contributions10/11€3k€3k=
Profit (loss) carried forward14€11k€3k
Amounts payable17/49€23k€5k
Amounts payable within one year42/48€23k€5k
Trade debts44-€245
Suppliers440/4-€245
Taxes, remuneration and social security45€12k€0
Taxes450/3€12k€0
Other amounts payable47/48€11k€4k
Income statement Code20232025
Other operating charges640/8€4k€1k
Non-recurring operating charges66A€3k-
Gross operating margin9900€-24k€-1k
Operating profit (loss)9901€-31k€-2k
Financial charges65/66B€69€73
Recurring financial charges65€69€73
Profit (loss) for the period before taxes9903€-31k€-2k
Income taxes67/77€0€3k
Profit (loss) for the period9904€-31k€-5k
Profit (loss) for the period to be appropriated9905€-31k€-5k
Appropriation of the result
Profit (loss) to be appropriated9906€11k€3k
Profit (loss) brought forward from the previous period14P€42k€8k

The notes to these accounts (2 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
26-03
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2024
15-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 76 days late
15-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 442 days late
2023
30-09
Financial Weakest financial yearnet €-31k ▼174%
Net result drops to €-31k, the lowest in the series; recovery starts the following year.
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Doverstraat 132-1341070 Anderlecht
Ground area
87 m²
Building footprint
82 m²
Volume, LiDAR
1,210 m³
Parcel 21302A0534/00X007, Brussels · tallest building 19.2 m, ±6 floors. Linked by address, not a title deed.
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21302A0534/00X007 Brussels 87 m² 1 · 82 m² 19.1 m · 6 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded30-04-2021
Fiscal year end30-09
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.